Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Europe In-Vitro Colorectal Cancer Screening Tests Market Outlook

The global in-vitro colorectal cancer screening tests market size was valued at USD 920.4 million in 2024, with Europe holding a significant market share. The market is driven by the rising prevalence of colorectal cancer across the region. It is expected to grow at a CAGR of 5.53% during the forecast period of 2025-2034, with the values likely to attain USD 1492.8 million by 2034.

Key Takeaways

  • According to the World Health Organization, the burden of colorectal cancer is expected to rise to about 3.2 million new cases per year and nearly 1.6 million deaths per year by 2024. The highest mortality rates have been witnessed in Eastern Europe.
  • Rising research activities are creating opportunities for Europe in-vitro colorectal cancer screening tests market growth. In February 2024, researchers at the Netherlands Cancer Institute, Amsterdam UMC, and Erasmus MC developed a new test called multitargetFIT-test (mtFIT), that measures hemoglobin with two additional proteins during the detection of pre-cursors of colorectal cancer.
  • The market is expected to be driven by clinical-stage diagnostics companies understanding the need to explore their screening technologies to detect colorectal cancer, brain cancer, and lung cancer. Dxcover Limited announced initiating three clinical trials to measure the efficacy of their liquid biopsy technology in the mentioned conditions.

Europe In-Vitro Colorectal Cancer Screening Tests Market Analysis

Colorectal cancer is the third most common cancer across the globe. It claims nearly 10% of all cancer cases and is the second leading cause of cancer-related deaths worldwide. According to the World Health Organization, in 2020, more than 1.9 million new cases of colorectal cancer were recorded globally. Europe, Australia, and New Zealand experienced the highest incidence rates, and the mortality rates were highest in Eastern Europe. It is expected that the burden of colorectal cancer will increase to 3.2 million new cases per year (an increase of 63%) by 2040, and 1.6 million deaths per year (an increase of 73%).

Europe in-vitro colorectal cancer screening tests market share is expected to be elevate with increasing strategic moves of market players. Considering the urgency of diagnosing colorectal cancer in its early stages with accuracy, there have been dedicated efforts to develop effective products. On January 9, 2024, a clinical-stage diagnostics company Dxcover Limited, pioneering in multi-omic spectral analysis (MOSA) for the early detection of multiple cancers, announced the initiation of three pivotal clinical trials, measuring the efficacy of the company’s liquid biopsy technology for the detection of brain, colorectal, and lung cancer. Their CREATE2 trial is focused on evaluating the diagnostic accuracy for colorectal cancer and high-risk adenoma in patients who have been going through colonoscopy. With colorectal cancer already difficult to diagnose in early detection screenings, diagnosis at these stages will enable positive patient outcomes.

Europe in-vitro colorectal cancer screening tests market growth is anticipated to be positively impacted by the researchers innovating new testing methods for the detection of precursors of colorectal cancer. For instance, in February 2024, researchers at the Netherlands Cancer Institute, Amsterdam UMC, and Erasmus MC developed a new test, titled multitargetFIT-test (mtFIT). With the existing FIT test, the patient’s stool is analysed for hemoglobin, however mtFIT measures hemoglobin and two additional proteins. mtFIT is targeted to detect cancer precursors more effectively. Notable outcomes have also been registered in a large prospective study, in which mtFIT effectively detected cancer precursors in comparison to the current FIT. Based on the diagnostic test guidelines in Europe, the next step is to produce the mtFIT test on a larger industrial scale. This is because the test can be included in existing FIT-based screening programs, as the screening logistics requirements are similar. To facilitate the availability of the test for CRC screening participants in the Netherlands and other places, a company called CRCbioscreen has also been established.

Europe In-Vitro Colorectal Cancer Screening Tests Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup Categories 
Testing Type Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests, Flexible Sigmoidoscopy, Others
Imaging Type Colonoscopy, Proctoscopy, CT scan, Ultrasound, MRI, PET Scan
End User Hospitals, Clinics, Diagnostics Laboratories
Country United Kingdom, Germany, France, Italy, Others

Europe In-vitro Colorectal Cancer Screening Tests Market: Competitor Landscape

The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Epigenomics AG
  • NOVIGENIX SA
  • Merck KGaA
  • Abbott
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd
  • Eiken Chemical Co., Ltd.
  • Beckman Coulter, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Testing Type
  • Imaging Type
  • End User
  • Region
Breakup by Testing Type
  • Fecal Occult Blood Tests
  • Biomarker Tests
  • CRC DNA Screening Tests
  • Flexible Sigmoidoscopy
  • Others
Breakup by Imaging Type
  • Colonoscopy
  • Proctoscopy
  • CT scan
  • Ultrasound
  • MRI
  • PET Scan
Breakup by End User
  • Hospitals
  • Clinics
  • Diagnostics Laboratories
  • Others
Breakup by Region
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Epigenomics AG 
  • NOVIGENIX SA
  • Merck KGaA
  • Abbott
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Qiagen NV
  •  F. Hoffmann-La Roche Ltd 
  • Eiken Chemical Co., Ltd.
  • Beckman Coulter, Inc. 

Europe In-Vitro Colorectal Cancer Screening Tests Market Report Snapshots

Europe In-Vitro Colorectal Cancer Screening Tests Market Size

Europe In-Vitro Colorectal Cancer Screening Tests Market Analysis

Europe In-Vitro Colorectal Cancer Screening Tests Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The Europe in-vitro colorectal cancer screening tests market is expected to be driven by the increasing research activities in the global market, which is anticipated to grow at a CAGR of 5.53% during the forecast period of 2025-2034, and is likely to reach a market value of USD 1492.8 million by 2034.

Factors aiding the market demand include increasing prevalence of colorectal cancer along with market players understanding the importance of urgent requirements for new and effective screening tests for early detection of cancer.

Major trends influencing the market growth include researchers innovating new testing methods for detecting colorectal cancer precursors. For instance, in February 2024, researchers at the Netherlands Cancer Institute, Amsterdam UMC, and Erasmus MC developed a new test, called multitargetFIT-test (mtFIT).

Based on the testing type, the market is segmented into fecal occult blood tests, biomarker tests, CRC DNA screening tests, and flexible sigmoidoscopy, among others.

By imaging type, the market is divided into colonoscopy, proctoscopy, CT scan, ultrasound, MRI, and PET scan, among others.

End users of the market are hospitals, clinics, and diagnostics laboratories.

The market segmentation by countries includes the United Kingdom, Germany, France, Italy and others.

The key players in the market are Epigenomics AG, NOVIGENIX SA, Merck KGaA, Abbott, Siemens Healthineers AG, Sysmex Corporation, F. Hoffmann-La Roche Ltd, Eiken Chemical Co., Ltd., Beckman Coulter, Inc., and Qiagen NV.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,299

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 4,899

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 5,899

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124